Rakuten Medical

Website

Rakuten Medical, Inc.

15 Investors
Biotechnology - Oncology Treatments
San Diego, CA

Rakuten Medical, Inc. is a biotechnology company focused on developing advanced cancer treatments through their innovative photoimmunotherapy technology. Their mission is to provide more precise and effective therapeutic options, specifically targeting cancer cells to minimize collateral damage to healthy tissues.

Products & Team

ASP-1929

PhotoimmunotherapySeed

ASP-1929 is a pioneering cancer treatment under development that employs Rakuten Medical's photoimmunotherapy technology. This approach uses antibodies that specifically bind to cancer cells and are activated by an external light source, enhancing treatment precision.

Value Proposition

ASP-1929 provides a targeted therapeutic option aimed at improving cancer treatment precision and effectiveness, reducing side effects compared to traditional methods.

Pain Points

The need for targeted, effective cancer treatments with reduced side effects

Light-activated therapySpecifically targets cancer cellsMinimizes damage to healthy tissue
Industry
Biotechnology
Primary business sector
Founded
2025
Year established
Location
San Diego, CA
Primary headquarters

Funding History

Total Raised:
$1.4M
E

Option to Acquire, Security Offering

Closed
December 2024
$1.4M
Raised
Progress
100%
Raised
$1.4M
Target
$1.4M
#000159521525000001